Daniel A. Culver DO

Pulmonology•Cleveland, OH

Critical Care Medicine

Staff Physician

Join to View Full Profile

9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273

Education & Training

Cleveland Clinic FoundationFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
Cleveland Clinic FoundationResidency, Internal Medicine, 1997 - 2000
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1996

Certifications & Licensure

OH State License 2000 - 2025
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2012 Jul 16
Completed
Phase 2
Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
Completed
Phase 2
Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis Start of enrollment: 2014 Mar 01
Completed
Phase 2
Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis Start of enrollment: 2014 Jan 01
Completed
Phase 2
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel Start of enrollment: 2016 Jul 01
Completed
Not Applicable
Patient Reported Outcome Instruments in Sarcoidosis Start of enrollment: 2017 Apr 01
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Association between preserved ratio impaired spirometry (PRISm) and COPD with coronary artery calcification measured by coronary computed tomography.
Purnadeo N Persaud, Lauren S Munoz Tremblay, Yanjun Wu, Peter Oro, Daniel A Culver
Chest. 2025-03-08
Diagnosis and Prognosis of Isolated Cardiac Sarcoidosis: Multidisciplinary Diagnosis Versus Japanese Circulation Society Criteria.
Manuel L Ribeiro Neto, Christine L Jellis, Ziad Taimeh, Paul Cremer, Anuhya V Pulapaka
The American Journal of Cardiology. 2025-02-15
Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis.
Ogugua Ndili Obi, Robert P Baughman, Elliott D Crouser, Mark W Julian, Landon W Locke
ERJ Open Research. 2025-01-01

Lectures

The World Association of Sarcoidosis and Other Granulomatous Disorders North American Conference 2012
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 10/4/2012

Press Mentions

Relationship Between Intermittent Hypoxia, COPD and ComorbiditiesJanuary 22nd, 2025
aTyr Pharma’s Fusion Protein Achieves Consistent Dose Response in Pulmonary Sarcoidosis TrialSeptember 16th, 2021
aTyr Pharma Announces Second Quarter 2021 Results and Provides Corporate UpdateAugust 10th, 2021
Join now to see all

Grant Support

Matrix Metalloproteinases And PPAR Gamma In SarcoidosisNational Heart, Lung, And Blood Institute2005–2009
Matrix Metalloproteinases And PPAR Gamma In SarcoidosisNational Center For Research Resources2007

Professional Memberships

American Osteopathic Association - AOA
Member